Stockreport

Factor Bioscience and Eterna Therapeutics Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases [Yahoo! ...

Eterna Therapeutics Inc.  (ERNA) 
PDF CAMBRIDGE, Mass. Oct. 17, 2024 "We are excited to collaborate with Factor to unlock the full potential of these transformative cell therapies," said Sanjeev Luther , [Read more]